Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Innovative Pharmaceutical Biotech ( (HK:0399) ) has shared an announcement.
Innovative Pharmaceutical Biotech Limited announced that during its Special General Meeting held on March 28, 2025, shareholders approved the appointment of SFAI (HK) CPA Limited as the company’s auditor. The resolution was passed unanimously, with all votes cast in favor. This decision is expected to enhance the company’s financial oversight and transparency, potentially strengthening its market position and stakeholder confidence.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited is a company in the pharmaceutical and biotechnology industry, focusing on developing innovative medical solutions and products. The company is incorporated in the Cayman Islands and continued in Bermuda, with its shares listed on the Hong Kong Stock Exchange.
YTD Price Performance: -15.71%
Average Trading Volume: 959,130
Technical Sentiment Signal: Buy
Current Market Cap: HK$322.5M
Find detailed analytics on 0399 stock on TipRanks’ Stock Analysis page.